Pharmacokinetic overview of ethinyl estradiol dose and bioavailability using two transdermal contraceptive systems and a standard combined oral contraceptive

Por Hofmann, Birte, Reinecke, Isabel, Schuett, Barbara, Merz, Martin, Zurth, Christian
Publicado no Int J Clin Pharmacol Ther (2014)

Phase 1 study of darolutamide (ODM-201): a new-generation androgen receptor antagonist, in Japanese patients with metastatic castration-resistant prostate cancer

Por Matsubara, Nobuaki, Mukai, Hirofumi, Hosono, Ako, Onomura, Mai, Sasaki, Masaoki, Yajima, Yoko, Hashizume, Kensei, Yasuda, Masanobu, Uemura, Miho, Zurth, Christian
Publicado no Cancer Chemother Pharmacol (2017)

Pharmacokinetics of single dose radium-223 dichloride (BAY 88-8223) in Japanese patients with castration-resistant prostate cancer and bone metastases

Por Yoshida, Keisuke, Kaneta, Tomohiro, Takano, Shoko, Sugiura, Madoka, Kawano, Tsuyoshi, Hino, Ayako, Yamamoto, Tou, Shizukuishi, Kazuya, Kaneko, Masato, Zurth, Christian, Inoue, Tomio
Publicado no Ann Nucl Med (2016)